# Sciegen Pharmaceuticals Inc – FDA Inspection, Apr 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/78debf30-0ef4-42cc-be44-6bb8ef0669d0
Source feed: FDA_Inspections

> FDA inspection 1204858 of Sciegen Pharmaceuticals Inc, April 21, 2023. Classification: Official Action Indicated (OAI). Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204858
- Company Name: Sciegen Pharmaceuticals Inc
- Inspection Date: 2023-04-21
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1317246 - 2026-05-15](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/a00d1c75-1c9e-4b7c-82cc-eda5065cbf25)
- [FDA Inspection 1297968 - 2025-12-19](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/dbc62b1e-da3f-4e51-b99e-d9e5f6698380)
- [FDA Inspection 1229682 - 2024-02-20](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/c0bb89dd-507e-46db-a766-fad3d39acd40)
- FDA Inspection 1178870 - 2022-09-02
- FDA Inspection 1159297 - 2021-12-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/xikui-chen/b320acb8-c976-4b42-bfdb-95b1701e7627)

Company: https://www.keypedia.com/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
